Verona Pharma
(VRNA)
undefined
undefined%
At close: undefined
41.55
0.34%
After-hours Dec 13, 2024, 05:48 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -54.58M | -68.70M | -55.57M | -65.15M | -51.41M | -30.62M | -34.06M | -7.37M | -13.29M | -5.90M | -4.64M | -4.18M | -2.87M | -2.93M | -2.60M | -2.17M | -2.61M | -1.31M | -12.04K |
| Depreciation & Amortization | 116.00K | 636.00K | 629.00K | 623.00K | 660.83K | 124.35K | 166.22K | 76.03K | 78.69K | 82.43K | 61.99K | 49.08K | 37.26K | 32.41K | 35.57K | 27.82K | 27.76K | 3.92K | - |
| Stock-Based Compensation | 19.01M | 14.12M | 25.43M | 22.18M | 3.20M | 3.68M | 3.94M | 710.54K | 591.03K | 299.13K | 308.11K | 108.81K | 281.02K | 64.82K | 21.02K | 57.11K | 212.20K | 583.84K | - |
| Other Working Capital | -14.44M | -3.59M | 3.58M | -715.00K | 1.40M | -138.31K | 7.19M | -914.54K | 1.97M | -445.62K | 409.61K | -138.92K | -85.39K | 273.18K | -90.55K | 149.37K | -23.80K | 39.18K | 15.49K |
| Other Non-Cash Items | -332.39K | 4.82M | 239.00K | 18.00K | -2.46M | -1.85M | -6.15M | -1.29M | 398.94K | 192.19K | 186.85K | 67.33K | 232.89K | 42.00K | -22.64K | 39.00K | 107.00K | 298.00K | -0.00 |
| Deferred Income Tax | -486.00K | - | -17.42M | -635.00K | 5.71M | 5.82M | 1.10M | 1.90M | 836.71K | 264.27K | 290.37K | 10.34K | -40.37K | -48.17K | 33.96K | -80.00K | -107.00K | -298.00K | - |
| Change in Working Capital | -13.95M | -10.74M | 13.44M | -2.11M | -45.89K | -138.31K | 7.03M | -914.54K | 1.97M | -445.62K | 409.61K | -138.92K | -85.39K | 273.18K | -90.55K | 149.37K | -23.80K | 39.18K | 15.49K |
| Operating Cash Flow | -50.22M | -59.86M | -33.25M | -45.08M | -44.34M | -22.98M | -27.97M | -6.89M | -9.41M | -5.51M | -3.39M | -4.08M | -2.44M | -2.56M | -2.62M | -1.98M | -2.39M | -687.68K | 3.44K |
| Capital Expenditures | - | -29.00K | -12.00K | -82.00K | -369.75K | -340.07K | -293.26K | -157.75K | -211.96K | -343.29K | -177.46K | -120.47K | -43.47K | -75.63K | -40.42K | -32.22K | -33.71K | -29.39K | - |
| Acquisitions | - | - | - | - | 319.92K | 323.57K | 49.36M | - | - | - | - | - | - | - | - | - | - | -31.35K | - |
| Purchase of Investments | - | - | - | - | -10.41M | -75.75M | -73.60M | - | - | - | - | - | - | - | - | - | - | -2.55M | - |
| Sales Maturities Of Investments | - | - | - | 9.79M | 59.18M | 81.67M | 6.87M | - | - | - | - | - | - | - | - | - | 2.58M | 51.80K | - |
| Other Investing Acitivies | - | -29.00K | -12.00K | 7.16M | 843.08K | 796.87K | -49.19M | 106.78K | 74.95K | 37.63K | 4.36K | 32.63K | 4.66K | 12.35K | 16.17K | 202.09K | 220.13K | 54.00K | 46.46K |
| Investing Cash Flow | - | -29.00K | -12.00K | 9.71M | 49.56M | 6.70M | -66.85M | -50.97K | -137.01K | -305.66K | -173.11K | -87.83K | -38.82K | -63.28K | -24.25K | 169.87K | 2.76M | -2.50M | 46.46K |
| Debt Repayment | 38.71M | 5.00M | - | 5.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | -2.75M | -13.98M | -6.85M | -12.81M | - | - | -31.40M | -4.38M | - | - | - | 1.01B | -26.51K | 83.34K | -87.32K | - | - | -654.38K | -86.03K |
| Financial Cash Flow | 92.87M | 140.82M | -6.12M | 192.34M | -558.56K | 1.09 | 85.47M | 50.84M | - | 20.39M | 2.97M | 1.64M | 3.29M | 1.35M | 3.25M | 3.57M | - | 3.35M | 1.64M |
| Net Cash Flow | 43.95M | 79.45M | -39.61M | 157.56M | 4.13M | -14.79M | -11.27M | 44.74M | -9.55M | 14.58M | -588.82K | -2.53M | 812.01K | -1.28M | 606.38K | 1.76M | 374.81K | 158.70K | 1.69M |
| Free Cash Flow | -50.22M | -59.89M | -33.27M | -45.16M | -44.71M | -23.32M | -28.26M | -7.05M | -9.62M | -5.85M | -3.57M | -4.20M | -2.49M | -2.64M | -2.66M | -2.01M | -2.42M | -717.07K | 3.44K |